| 000 | 01457 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513061419.0 | ||
| 264 | 0 | _c19930927 | |
| 008 | 199309s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/0140-6736(93)91761-a _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDolman, K M | |
| 245 | 0 | 0 |
_aVasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cSep 1993 |
||
| 300 |
_a651-2 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAntibodies, Antineutrophil Cytoplasmic |
| 650 | 0 | 4 |
_aAutoantibodies _ximmunology |
| 650 | 0 | 4 | _aBiomarkers |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperthyroidism _xdrug therapy |
| 650 | 0 | 4 |
_aImmunoglobulin G _ximmunology |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPropylthiouracil _xadverse effects |
| 650 | 0 | 4 |
_aVasculitis _xchemically induced |
| 700 | 1 | _aGans, R O | |
| 700 | 1 | _aVervaat, T J | |
| 700 | 1 | _aZevenbergen, G | |
| 700 | 1 | _aMaingay, D | |
| 700 | 1 | _aNikkels, R E | |
| 700 | 1 | _aDonker, A J | |
| 700 | 1 | _avon dem Borne, A E | |
| 700 | 1 | _aGoldschmeding, R | |
| 773 | 0 |
_tLancet (London, England) _gvol. 342 _gno. 8872 _gp. 651-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0140-6736(93)91761-a _zAvailable from publisher's website |
| 999 |
_c8102472 _d8102472 |
||